SG/PUT/SANOFI/70/0.1/20.12.24 Share Price

Warrant

DE000SU130W4

Market Closed - Deutsche Boerse AG 20:37:38 28/06/2024 BST
0.078 EUR -3.70% Intraday chart for SG/PUT/SANOFI/70/0.1/20.12.24
Current month+11.43%
1 month-1.27%
Date Price Change
28/06/24 0.078 -3.70%
27/06/24 0.081 +8.00%
26/06/24 0.075 +17.19%
25/06/24 0.064 -11.11%
24/06/24 0.072 -22.58%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 08:37 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying SANOFI
IssuerLogo Issuer Société Générale Société Générale
WKN SU130W
ISINDE000SU130W4
Date issued 13/11/2023
Strike 70
Maturity 20/12/2024 (173 Days)
Parity 10 : 1
Emission price 0.31
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.32
Lowest since issue 0.058
Spread 0.015
Spread %16.48%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
89.94 EUR
Average target price
107.9 EUR
Spread / Average Target
+19.93%
Consensus